Clinical Research Award
The Clinical Research Award from Alzheimer's Research UK funds investigator-led experimental medicine and early-phase clinical studies to advance dementia therapies.
Funder: Alzheimer's Research UK
Due Dates: Rolling (Expression of Interest) | February & July (Full Application outcomes)
Funding Amounts: Flexible funding and duration, tailored to each proposal; no set minimum or maximum.
Summary: Supports investigator-led experimental medicine and early-phase clinical research to accelerate dementia therapies.
Key Information: Lead Applicant must be UK-based; international and industry partners encouraged.
Description
The Clinical Research Award from Alzheimer's Research UK is designed to support ambitious, investigator-led studies that advance therapeutic interventions for dementia and strengthen the clinical research pipeline. This scheme provides flexible funding for high-quality experimental medicine studies—including early-phase (1b/2a) clinical trials—and value-added sub-studies across all phases of clinical research. The award aims to generate essential biological and clinical evidence to progress promising therapies toward larger trials and real-world impact, with a strong emphasis on collaboration across academia, industry, and patient communities.
